These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 35985089)
1. Mutually exclusive expression of EZH2 and H3K27me3 in non-small cell lung carcinoma. Onishi T; Takashima T; Kurashige M; Ohshima K; Morii E Pathol Res Pract; 2022 Oct; 238():154071. PubMed ID: 35985089 [TBL] [Abstract][Full Text] [Related]
2. Analysis of H3K27me3 expression and DNA methylation at CCGG sites in smoking and non-smoking patients with non-small cell lung cancer and their clinical significance. Zhu K; Deng Y; Weng G; Hu D; Huang C; Matsumoto K; Nagayasu T; Koji T; Zheng X; Jiang W; Lin G; Cai Y; Weng G; Chen X Oncol Lett; 2018 May; 15(5):6179-6188. PubMed ID: 29616099 [TBL] [Abstract][Full Text] [Related]
3. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer. Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2. Ye J; Fu Y; Wang Z; Yu J Cell Biol Toxicol; 2022 Dec; 38(6):1047-1062. PubMed ID: 34545456 [TBL] [Abstract][Full Text] [Related]
5. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Holm K; Grabau D; Lövgren K; Aradottir S; Gruvberger-Saal S; Howlin J; Saal LH; Ethier SP; Bendahl PO; Stål O; Malmström P; Fernö M; Rydén L; Hegardt C; Borg Å; Ringnér M Mol Oncol; 2012 Oct; 6(5):494-506. PubMed ID: 22766277 [TBL] [Abstract][Full Text] [Related]
6. Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia. Sihavong P; Kitkumthorn N; Srimaneekarn N; Bumalee D; Lapthanasupkul P Head Neck Pathol; 2021 Jun; 15(2):408-415. PubMed ID: 32720035 [TBL] [Abstract][Full Text] [Related]
7. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma. Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells. Chen W; Wang HT; Ji JF; Wang ZY; Shi T; Wu MH; Yu PJ Neoplasma; 2022 May; 69(3):680-690. PubMed ID: 35400167 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Venneti S; Garimella MT; Sullivan LM; Martinez D; Huse JT; Heguy A; Santi M; Thompson CB; Judkins AR Brain Pathol; 2013 Sep; 23(5):558-64. PubMed ID: 23414300 [TBL] [Abstract][Full Text] [Related]
10. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3. Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307 [TBL] [Abstract][Full Text] [Related]
11. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Li CP; Cai MY; Jiang LJ; Mai SJ; Chen JW; Wang FW; Liao YJ; Chen WH; Jin XH; Pei XQ; Guan XY; Zeng MS; Xie D Carcinogenesis; 2016 Jun; 37(6):557-566. PubMed ID: 27207647 [TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain. An Q; Sun C; Li R; Chen S; Gu X; An S; Wang Z J Neuroinflammation; 2021 May; 18(1):117. PubMed ID: 34020664 [TBL] [Abstract][Full Text] [Related]
13. [Distributions of H3K27me3 and its modification enzymes in different tissues of mice]. Wang Y; Wang X; Zhang R; Zhang Z; Wang Y; Yang B; Wang G; Zhang X; Ma F; Xu H; Wu X; Zhang F; Li Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1491-1497. PubMed ID: 29268852 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer. Huqun ; Ishikawa R; Zhang J; Miyazawa H; Goto Y; Shimizu Y; Hagiwara K; Koyama N Cancer; 2012 Mar; 118(6):1599-606. PubMed ID: 21837672 [TBL] [Abstract][Full Text] [Related]
16. Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney. Jia Y; Reddy MA; Das S; Oh HJ; Abdollahi M; Yuan H; Zhang E; Lanting L; Wang M; Natarajan R J Biol Chem; 2019 Aug; 294(34):12695-12707. PubMed ID: 31266808 [TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2). Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862 [TBL] [Abstract][Full Text] [Related]
19. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects. Xu S; Xu Y; Yin M; Zhang S; Liu P; Koroleva M; Si S; Little PJ; Pelisek J; Jin ZG Theranostics; 2018; 8(11):3007-3021. PubMed ID: 29896299 [No Abstract] [Full Text] [Related]
20. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression. Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]